Paid Clinical Trials in Wichita, KS
As of July 2026, 120 paid clinical trials are recruiting in Wichita, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Wichita offers studies at sites including Ascension Via Christi Hospitals Wichita for conditions such as Coronary Artery Disease, Hypertension, Heart Failure, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Wichita
Trials by drug in Wichita
Filter results
Newly added in Wichita
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
115 clinical trials
↓ Download CSVA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
SELUTION 4 De Novo Small Vessel IDE Trial
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Top Research Study Locations in Wichita
Researchers run research studies in Wichita, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ascension Via Christi Hospitals Wichita | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 15 |
| Cancer Center of Kansas | Breast Cancer, Colorectal Neoplasms, Advanced Breast Cancer | 10 |
| Cancer Center of Kansas - Wichita | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Cancer Center of Kansas-Wichita Medical Arts Tower | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 9 |
| Wichita Urology Group | Prostate Cancer, High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer | 8 |
| Wesley Medical Center | Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | 6 |
| Cardiovascular Research Institute of Kansas | Coronary Artery Disease, Acute Myocardial Infarction, Aortic Stenosis | 5 |
| Ascension Via Christi St. Francis | Aortic Stenosis, Aortic Stenosis, Calcific, Aortic Valve Stenosis | 5 |
| Ascension Via Christi Saint Francis | Coronary Artery Disease, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 3 |
| Kansas Gastroenterology, LLC | Bowel; Stricture, Crohn Disease, Esophageal Stricture | 3 |
| Heartland Research Associates, LLC - An AMR Company | Acute Migraine, Migraine | 2 |
| Kansas Gastroenterology, LLC under Clinical Trials Network | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Kansas Nephrology Research Institute, LLC | Heart Failure, Kidney Disease, Chronic | 2 |
| Robert J Dole VA Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of the Colon | 2 |
| Via Christi Regional Medical Center - St. Francis Campus | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 2 |
| West Houston Area Clinical Trial Consultants, LLC | Heart Failure | 2 |
| Wichita Urology Group PA | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Progressive Metastatic Castrate Resistant Prostate Cancer | 2 |
| Ascension Via Christi Research | Heart Valve Diseases, Tricuspid Regurgitation, Tricuspid Valve Disease | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AMR Wichita East, KS (Heartland Research Associates) | Diabetic Peripheral Neuropathic Pain | 1 |
| Advanced Pain Medicine Assocs | Lumbar Spinal Stenosis | 1 |
| Alliance for Multispecialty Research | Hypercholesterolaemia | 1 |
| Alliance for Multispecialty Research (AMR) - Wichita West | Migraine | 1 |
Active & Upcoming Studies in Wichita (2026)
Recruiting trials in Wichita grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (39 active studies)
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
- TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) · Phase 1, Phase 2 · Novartis Pharmaceuticals
Cardiovascular (22 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. · Phase 2 · AstraZeneca
Diabetes & metabolic (8 active studies)
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (8 active studies)
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Eye & vision (1 active study)
- IC-8 Apthera IOL New Enrollment Post Approval Study · Bausch & Lomb Incorporated
Common conditions studied in Wichita
- Coronary Artery Disease (6 active studies)
- Hypertension (5 active studies)
- Heart Failure (4 active studies)
- Obesity (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Aortic Valve Stenosis (3 active studies)
Leading research sponsors in Wichita
- AstraZeneca
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Boehringer Ingelheim
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Wichita?
There are approximately 120 recruiting clinical trials in Wichita, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Wichita pay participants?
Most recruiting trials in Wichita compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Wichita?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Wichita?
The most common conditions under active study in Wichita include Coronary Artery Disease (6), Hypertension (5), Heart Failure (4), Obesity (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Wichita?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Wichita on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Wichita?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Wichita?
Recruiting research sites in Wichita include Ascension Via Christi Hospitals Wichita, Cancer Center of Kansas, Cancer Center of Kansas - Wichita, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Wichita right now?
The largest active categories in Wichita are Cancer & tumors (39), Cardiovascular (22), Diabetes & metabolic (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.